Streetbeat News

Analyst Ratings

TXN

Truist Securities analyst William Stein maintains a Hold rating on Texas Instruments (NASDAQ:TXN) and lowers the price target from $166 to $165 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 10:03 pm

THC

Truist Securities analyst David Macdonald has maintained a Buy rating on Tenet Healthcare (NYSE:THC) and increased the price target from $92 to $105 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 10:02 pm

SWI

Truist Securities analyst Terry Tillman has maintained a Hold rating on SolarWinds (NYSE:SWI) and increased the price target from $11 to $13 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 10:00 pm

PCTY

Truist Securities analyst Terry Tillman has maintained a Buy rating on Paylocity Holding (PCTY) but lowered the price target from $250 to $200 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:59 pm

ORLY

Truist Securities analyst Scot Ciccarelli maintains a Buy rating on O'Reilly Automotive (ORLY) and raises the price target from $1080 to $1149 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:57 pm

MAS

Truist Securities analyst Keith Hughes has maintained a Buy rating on Masco Corporation (NYSE:MAS) and increased the price target from $65 to $81 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:55 pm

IBEX

Truist Securities analyst Tobey Sommer maintains a Buy rating on IBEX (NASDAQ:IBEX) but lowers the price target from $25 to $22 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:54 pm

GL

Truist Securities analyst Mark Hughes has maintained a Hold rating on Globe Life (NYSE:GL) and increased the price target from $115 to $125 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:50 pm

EFX

Truist Securities analyst Andrew Jeffrey has maintained a Buy rating on Equifax (NYSE:EFX) and increased the price target from $270 to $285 as of 8th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:49 pm

EHC

Truist Securities analyst David Macdonald maintains a Buy rating on Encompass Health (NYSE:EHC) and raises the price target from $82 to $86.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 9:47 pm